DK1001759T3 - Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider - Google Patents

Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider

Info

Publication number
DK1001759T3
DK1001759T3 DK97941503T DK97941503T DK1001759T3 DK 1001759 T3 DK1001759 T3 DK 1001759T3 DK 97941503 T DK97941503 T DK 97941503T DK 97941503 T DK97941503 T DK 97941503T DK 1001759 T3 DK1001759 T3 DK 1001759T3
Authority
DK
Denmark
Prior art keywords
alkanes
amides
fatty acids
long chain
chain alcohols
Prior art date
Application number
DK97941503T
Other languages
English (en)
Inventor
David H Katz
John F Marcelletti
Laura E Pope
Mohammed H Khalil
Lee R Katz
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/916,624 external-priority patent/US5952392A/en
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Application granted granted Critical
Publication of DK1001759T3 publication Critical patent/DK1001759T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK97941503T 1996-09-17 1997-09-10 Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider DK1001759T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71500996A 1996-09-17 1996-09-17
US08/916,624 US5952392A (en) 1996-09-17 1997-08-22 Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
PCT/US1997/016007 WO1998011887A2 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides

Publications (1)

Publication Number Publication Date
DK1001759T3 true DK1001759T3 (da) 2005-10-10

Family

ID=27109257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941503T DK1001759T3 (da) 1996-09-17 1997-09-10 Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider

Country Status (16)

Country Link
EP (2) EP1557167A1 (da)
JP (1) JP3739098B2 (da)
KR (2) KR100528816B1 (da)
CN (1) CN1213748C (da)
AT (1) ATE299700T1 (da)
AU (1) AU742929B2 (da)
BR (1) BR9711501A (da)
CA (1) CA2273960C (da)
DE (1) DE69733778T2 (da)
DK (1) DK1001759T3 (da)
ES (1) ES2245004T3 (da)
IL (2) IL129033A0 (da)
MX (1) MXPA99002575A (da)
PL (1) PL189618B1 (da)
PT (1) PT1001759E (da)
WO (1) WO1998011887A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
DE69739583D1 (de) 1996-11-14 2009-10-29 Lipomedica Ehf Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
AU7928698A (en) 1997-06-20 1999-01-04 James Clair A skin-protective composition
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
SE0102289D0 (sv) * 2001-06-27 2001-06-27 Anders Hamberger New use of compound
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
WO2004032824A2 (en) 2002-10-10 2004-04-22 Yeda Research And Development Co. Ltd. Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
KR200449517Y1 (ko) * 2008-01-23 2010-07-15 김영중 선박의 조향장치용 헬름
KR100971276B1 (ko) * 2008-05-29 2010-07-20 김영중 조향장치
US9242923B2 (en) 2010-03-11 2016-01-26 Chemic Laboratories Inc. Compositons and methods
CN102702061B (zh) * 2012-06-07 2013-04-24 浙江维康药业有限公司 一种盐酸水苏碱化合物及含有该化合物的药物组合物
JP6125962B2 (ja) * 2013-09-24 2017-05-10 株式会社デンソー 抗ウイルス剤
FR3080038B1 (fr) 2018-04-16 2020-10-09 Oreal Composition cosmetique pour fibres keratiniques
FR3080034B1 (fr) * 2018-04-16 2020-04-24 L'oreal Composition cosmetique pour fibres keratiniques
KR102611242B1 (ko) * 2021-05-17 2023-12-08 충남대학교 산학협력단 알케인을 유효성분으로 함유하는 항바이러스용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
WO1994016061A1 (en) * 1993-01-15 1994-07-21 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
SG43833A1 (en) * 1993-12-13 1997-11-14 Lidak Pharmaceuticals Sucrose ester-c20 to c25 alcohol formulations

Also Published As

Publication number Publication date
EP1001759B1 (en) 2005-07-20
ES2245004T3 (es) 2005-12-16
KR20030097605A (ko) 2003-12-31
CA2273960C (en) 2003-12-30
JP3739098B2 (ja) 2006-01-25
CN1244121A (zh) 2000-02-09
EP1557167A1 (en) 2005-07-27
AU4339797A (en) 1998-04-14
WO1998011887A2 (en) 1998-03-26
BR9711501A (pt) 2004-05-25
MXPA99002575A (es) 2004-07-29
PL189618B1 (pl) 2005-08-31
JP2001521490A (ja) 2001-11-06
PT1001759E (pt) 2005-10-31
WO1998011887A3 (en) 1998-06-25
PL332455A1 (en) 1999-09-13
DE69733778T2 (de) 2006-04-20
AU742929B2 (en) 2002-01-17
KR100528816B1 (ko) 2005-11-16
IL129033A0 (en) 2000-02-17
DE69733778D1 (de) 2005-08-25
KR20000036210A (ko) 2000-06-26
CN1213748C (zh) 2005-08-10
EP1001759A2 (en) 2000-05-24
KR100528815B1 (ko) 2005-11-16
ATE299700T1 (de) 2005-08-15
IL163865A0 (en) 2005-12-18
CA2273960A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DK1001759T3 (da) Virusinhibering med langkædede alkoholer, alkaner, fedtsyrer og amider
PT999826E (pt) Formulacao auto-emulsionante para compostos lipofilos
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
EP0264904A3 (en) Pharmaceutical compositions containing benzoyl urea derivatives
KR910700062A (ko) 마가이닌 펩타이드의 결실 동족체
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
GB0121580D0 (en) Novel compounds
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
ES2073755T3 (es) Acidos hidroxamicos y n-hidroxiureas antiinflamatorios.
FI831070A0 (fi) Salicylsyraderivat, foerfarande foer deras framstaellning, pao dessa foereningar baserade farmaceutprodukter och deras anvaendning
FI945654A (fi) Desferrioksamiini-B:n suolat ja niiden käyttö oraalisesti vaikuttavina rautakelaattoreina
DE59008795D1 (de) Substituierte Acrylsäureester.
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
ES2052493T3 (es) Utilizacion de inhibidores de girasa para la descontaminacion de cultivos celulares infectados con micoplasma.
ES2053686T3 (es) Nuevos di(met)acrilatos, procedimiento para su fabricacion y su empleo.
SE9402241L (sv) Inhibitor
JPS55336A (en) Preparation of amine amide compound
KR910000645A (ko) 개선된 경련치료제
ES2036215T3 (es) Nuevos derivados de na n-(2,4,6-trimetoxibenzoil)-3-propil) peperidina, sus procedimientos preparacion y su aplicacion en terapeutica.
IT1318424B1 (it) Composti con attivita' anti-hiv.
PT88320A (pt) Process for the preparation of thionoalkawephosphonates of o (6-methyl-2-alkyl-pyrimidine-4-ilo) and of o-alkyl with insecticide acaricide and/or nematodocide effect
DK0625140T3 (da) Cyclopropyl-N-hydroxyurinstof og -N-hydroxyacetamider, som inhiberer lipoxygenase